Browsing by Author "Sarma, H. D."
Now showing 1 - 20 of 187
Results Per Page
Sort Options
- 131I-Nimotuzumab - A potential radioimmunotherapeutic agent in treatment of tumors expressing EGFR(2015) Kameswaran, M.; Samuel, G.; Sarma, H. D.; Shinde, S. N.; Dash, A.; Venkatesh, M.
- 131I-Nimotuzumab - A potential radioimmunotherapeutic agent in treatment of tumors expressing EGFR(2015) Kameswaran, M.; Samuel, G.; Sarma, H. D.; Shinde, S. N.; Dash, A.; Venkatesh, M.
- 166Ho-labeled hydroxyapatite particles: A possible agent for liver cancer therapy(2009) Das, T.; Chakraborty, S.; Sarma, H. D.; Venkatesh, M.; Banerjee, S.
- 170Tm-EDTMP: a potential cost-effective alternative to 89SrCl2 for bone pain palliation(2009) Das, T.; Chakraborty, S.; Sarma, H. D.; Tandon, P.; Banerjee, S.; Venkatesh, M.; Pillai, M. R. A.
- 175Yb labeled polyaminophosphonates as potential agents for bone pain palliation(2004) Mathew, B.; Chakraborty, S.; Das, T.; Sarma, H. D.; Banerjee, S.; Samuel, G.; Venkatesh, M.; Pillai, M. R. A.
- 177Lu labelled polyaminophosphonates as potential agents for bone pain palliation(2002) Chakraborty, S.; Das, T.; Unni, P. R.; Sarma, H. D.; Samuel, G.; Banerjee, S.; Venkatesh, M.; Ramamoorthy, N.; Pillai, M. R. A.
- 177Lu-DOTMP: A viable agent for palliative radiotherapy of painful bone metastasis(2008) Das, T.; Chakraborty, S.; Sarma, H. D.; Banerjee, S.
- 177Lu-EDTMP: A viable bone pain palliative in skeletal metastasis(2008) Chakraborty, S.; Das, T.; Banerjee, S.; Balogh, L.; Chaudhari, P. R.; Sarma, H. D.; Polyak, A.; Mathe, D.; Venkatesh, M.; Janoki, G.; Pillai, M. R. A.
- 177Lu-labeled carbon nanospheres: A new entry in the field of targeted radionanomedicine(2016) Satpati, D.; Satpati, A.; Pamale, Y.; Chandan Kumar; Sharma, R.; Sarma, H. D.; Banerjee, S.
- 177Lu-labeled cyclic Asn-Gly-Arg peptide tagged carbon nanospheres as tumor targeting radio-nanoprobes(2018) Vats, K.; Satpati, A. K.; Sharma, R.; Sarma, H. D.; Satpati, D.; Dash, A.
- 177Lu-labeled cyclic polyaminophosphonates as potential agents for bone pain palliation(2002) Das, T.; Chakraborty, S.; Unni, P. R.; Banerjee, S.; Samuel, G.; Sarma, H. D.; Venkatesh, M.; Pillai, M. R. A.
- 188Re-labeled hydroxyapatite particles for radiation synovectomy(2003) Kothari, K.; Suresh, S.; Sarma, H. D.; Meera, V.; Pillai, M. R. A.
- '4+1' Mixed Ligand Strategy for the Preparation of 99mTc-Radiopharmaceuticals for Hypoxia Detecting Applications(2017) Vats, K.; Mallia, M. B.; Mathur, A.; Sarma, H. D.; Banerjee, S.
- 64CuCl2 produced by direct neutron activation route as a cost-effective probe for cancer imaging: The journey has begun(2015) Chakravarty, R.; Chakraborty, S.; Vimalnath, K. V.; Shetty, P.; Sarma, H. D.; Hassan, P. A.; Dash, A.
- 68Ga labeled Erlotinib: A novel PET probe for imaging EGFR over-expressing tumors(2017) Jain, A.; Kameswaran, M.; Pandey, U.; Prabhash, K.; Sarma, H. D.; Dash, A.
- 68Ga labeled fatty acids for cardiac metabolic imaging: Influence of different bifunctional chelators(2016) Jain, A.; Mathur, A.; Pandey, U.; Sarma, H. D.; Dash, A.
- 68Ga-Chelation and comparative evaluation of N,N′-bis-[2-hydroxy-5-(carboxyethyl)benzyl]ethylenediamine-N,N′-diacetic acid (HBED-CC) conjugated NGR and RGD peptides as tumor targeted molecular imaging probes(2017) Satpati, D.; Sharma, R.; Chandan Kumar; Sarma, H. D.; Dash, A.
- 68Ga-labeled PET tracers for targeting tumor hypoxia: Role of bifunctional chelators on pharmacokinetics(2021) Mittal, S.; Sharma, R.; Mallia, M. B.; Sarma, H. D.
- 68Ga-labeling of internalizing RGD (iRGD) peptide functionalized with DOTAGA and NODAGA chelators(2020) Satpati, D.; Vats, K.; Sharma, R.; Sarma, H. D.; Dash, A.
- 68Ga-NOTA-ubiquicidin fragment for PET imaging of infection: From bench to bedside(2018) Mukherjee, A.; Bhatt, J.; Shinto, A.; Korde, A.; Mukesh Kumar; Sarma, H. D.; Dash, A.